FTC Sues to Block Amgen Acquisition of Horizon Therapeutics     On May 16, the Federal Trade Commission (FTC) announced that it has filed a lawsuit in federal court to block biopharmaceutical giant Amgen from acquiring Horizon Therapeutics, saying the deal would allow Amgen to leverage its portfolio of blockbuster drugs to entrench the monopoly positions …

FTC Sues to Block Amgen Acquisition of Horizon Therapeutics Read More »